PROCEPT BioRobotics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	245.64	286.5	333.73	257.22	221.86	304.32
Cash & Short-Term Investments	245.64	286.5	333.73	257.22	221.86	304.32
Cash Growth	-22.32%	-14.15%	29.74%	15.94%	-27.10%	203.93%
Accounts Receivable	96.39	70.69	83.5	48.38	15.27	4.46
Inventory	77.54	83.53	56.17	39.76	28.54	13.15
Other Current Assets	8.47	9.65	8.45	5.21	6.95	4.24
Total Current Assets	428.03	450.38	481.84	350.57	272.63	326.17
Net Property, Plant & Equipment	48.9	47.94	45.65	48.99	32.14	8.32
Other Intangible Assets	0.64	0.71	0.93	1.2	1.48	1.75
Other Long-Term Assets	9.49	9.06	5.59	3.96	3.09	0.78
Total Assets	487.06	508.08	534.02	404.72	309.33	337.02
Accounts Payable	18.85	17.29	10.03	13.5	9.39	2.03
Accrued Expenses	18.48	23.18	21.54	16.89	13.45	6.48
Current Portion of Leases	2.36	2.21	1.91	1.68	2.13	2.11
Unearned Revenue	13.7	13.05	9.57	5.66	2.86	1.03
Other Current Liabilities	10.25	10.07	10.09	8.2	7.47	4.61
Total Current Liabilities	63.64	65.8	53.13	45.93	35.29	16.24
Long-Term Debt	51.66	51.62	51.47	51.34	51.21	50
Long-Term Leases	23.97	24.65	26.87	26.18	23.98	1.99
Other Long-Term Liabilities	0.12	0.15	0.32	0.52	1.78	1.7
Total Long-Term Liabilities	75.76	76.42	78.66	78.04	76.97	53.69
Total Liabilities	139.4	142.21	131.8	123.97	112.26	69.93
Additional Paid-in Capital	1,021	1,007	948.09	735.24	545.75	528.67
Accumulated Other Comprehensive Income	-0.02	0.04	0.11	0.08	-0.01	-0.05
Retained Earnings	-673.2	-641.56	-545.99	-454.57	-348.68	-261.52
Total Common Shareholders' Equity	347.67	365.87	402.22	280.75	197.07	267.09
Shareholders' Equity	347.67	365.87	402.22	280.75	197.07	267.09
Total Liabilities & Equity	487.06	508.08	534.02	404.72	309.33	337.02
Total Debt	78	78.48	80.25	79.2	77.32	54.1
Net Cash (Debt)	167.65	208.02	253.48	178.02	144.54	250.22
Net Cash Growth	-28.48%	-17.93%	42.39%	23.16%	-42.23%	451.53%
Net Cash Per Share	3.00	3.75	4.86	3.77	3.25	15.18
Book Value	347.67	365.87	402.22	280.75	197.07	267.09
Book Value Per Share	6.22	6.59	7.72	5.94	4.44	16.21
Tangible Book Value	347.03	365.16	401.29	279.55	195.6	265.34
Tangible Book Value Per Share	6.20	6.57	7.70	5.92	4.41	16.10

SEC Filings: 10-K · 10-Q